precirol has been researched along with glyceryl behenate in 20 studies
| Studies (precirol) | Trials (precirol) | Recent Studies (post-2010) (precirol) | Studies (glyceryl behenate) | Trials (glyceryl behenate) | Recent Studies (post-2010) (glyceryl behenate) |
|---|---|---|---|---|---|
| 81 | 0 | 52 | 160 | 3 | 104 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 14 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amighi, K; Hamdani, J; Moës, AJ | 3 |
| Danker, K; Korting, HC; Kramer, KD; Lombardi Borgia, S; Mehnert, W; Regehly, M; Röder, B; Schäfer-Korting, M; Sivaramakrishnan, R | 1 |
| Gavini, E; Giunchedi, P; Juliano, C; Karlsen, J; Marchetti, M; Sanna, V; Sharma, R; Usai, M | 1 |
| Amighi, K; Goole, J; Hamdani, J; Moës, AJ | 1 |
| Blanco-Prieto, MJ; Campanero, MA; de la Iglesia-Vicente, J; Estella-Hermoso de Mendoza, A; Lana, H; Mollinedo, F; Villa-Pulgarin, JA | 1 |
| Sznitowska, M; Wolska, E | 1 |
| Arranja, AG; Gouveia, LF; Videira, MA | 1 |
| Kumar, A; Sawant, K; Vaghasiya, H | 1 |
| Pradhan, M; Singh, D; Singh, MR | 1 |
| Cao, QR; Cao, Y; Cui, JH; Shi, LL; Zhu, XY | 1 |
| Feichtinger, A; Jedinger, N; Khinast, J; Mohr, S; Roblegg, E; Schrank, S | 1 |
| Abou Youssef, NA; Boraie, NA; El-Massik, MA; Kassem, AA | 1 |
| Adelli, G; ElSohly, MA; Gul, W; Hingorani, T; Majumdar, S; Punyamurthula, NS; Repka, MA | 1 |
| Butani, D; Misra, A; Yewale, C | 1 |
| Boraei, N; Ismail, F; Refaat, A; Sokar, M | 1 |
| Baranska, H; Cal, K; Pietkiewicz, J; Sznitowska, M; Wolska, E | 1 |
| Ahmad, M; Ahmed, K; Nasiri, MI; Qazi, F; Shoaib, MH; Yousuf, RI | 1 |
| Doktorovova, S; Silva, AM; Souto, EB; Zielinska, A | 1 |
20 other study(ies) available for precirol and glyceryl behenate
| Article | Year |
|---|---|
Development and evaluation of prolonged release pellets obtained by the melt pelletization process.
Topics: Ciprofloxacin; Delayed-Action Preparations; Diglycerides; Drug Compounding; Electron Probe Microanalysis; Excipients; Fatty Acids; Ketoprofen; Lactose; Microscopy, Electron, Scanning; Phenylephrine; Tablets | 2002 |
Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets.
Topics: Calorimetry, Differential Scanning; Crystallization; Delayed-Action Preparations; Diglycerides; Excipients; Fatty Acids; Rheology; Technology, Pharmaceutical; Temperature; X-Ray Diffraction | 2003 |
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Topics: Administration, Topical; Animals; Crystallization; Diglycerides; Drug Carriers; Emulsions; Fatty Acids; Fluorescent Dyes; In Vitro Techniques; Lipids; Nanoparticles; Oils; Oleic Acid; Oxazines; Particle Size; Skin; Skin Absorption; Spectrometry, Fluorescence; Surface Properties; Swine; Water | 2005 |
Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: preliminary studies.
Topics: Dermatologic Agents; Diglycerides; Drug Carriers; Drug Compounding; Drug Stability; Emulsions; Fatty Acids; Microbial Sensitivity Tests; Particle Size; Plant Oils; Propionibacterium acnes; Volatilization | 2005 |
In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
Topics: Adult; Algorithms; Biological Availability; Delayed-Action Preparations; Diglycerides; Drug Compounding; Drug Delivery Systems; Fasting; Fatty Acids; Humans; Hydrogen-Ion Concentration; Male; Methylcellulose; Middle Aged; Riboflavin; Sodium Bicarbonate; Tartrates | 2006 |
Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization.
Topics: Ciprofloxacin; Delayed-Action Preparations; Diglycerides; Drug Compounding; Excipients; Fatty Acids; Sodium Bicarbonate; Tetracycline; Theophylline | 2006 |
Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles.
Topics: Animals; Diglycerides; Fatty Acids; Humans; Leukemic Infiltration; Lymph Nodes; Lymphoma; Mice; Nanoparticles; Neoplasms, Experimental; Phospholipid Ethers | 2012 |
Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM).
Topics: Crystallization; Cyclosporine; Delayed-Action Preparations; Diglycerides; Drug Stability; Drug Storage; Excipients; Fatty Acids; Gels; Immunosuppressive Agents; Lipids; Microspheres; Ophthalmic Solutions; Particle Size; Polysorbates; Surface-Active Agents; Technology, Pharmaceutical; Time Factors; Triglycerides | 2013 |
Experimental design towards an optimal lipid nanosystem: a new opportunity for paclitaxel-based therapeutics.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Diglycerides; Fatty Acids; Mice; Nanoparticles; Paclitaxel | 2013 |
Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride.
Topics: Administration, Topical; Animals; Antifungal Agents; Candida albicans; Candidiasis; Delayed-Action Preparations; Diglycerides; Drug Stability; Fatty Acids; Female; In Vitro Techniques; Male; Nanoparticles; Naphthalenes; Rats; Skin; Terbinafine | 2013 |
Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders.
Topics: Acrylates; Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Delayed-Action Preparations; Diffusion Chambers, Culture; Diglycerides; Drug Compounding; Drug Liberation; Drug Stability; Fatty Acids; Gels; Goats; Nanoparticles; Particle Size; Permeability; Skin; Skin Absorption; Stearic Acids; Triamcinolone Acetonide | 2016 |
Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.
Topics: Antiviral Agents; Biological Transport; Caco-2 Cells; Cell Survival; Diglycerides; Drug Liberation; Fatty Acids; Glycerides; Humans; Microscopy, Electron, Transmission; Nanoparticles; Poloxamer; Polyvinyl Alcohol; Solubility; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; X-Ray Diffraction; Zanamivir | 2015 |
Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids.
Topics: Acetaminophen; Chemistry, Pharmaceutical; Codeine; Diglycerides; Drug Compounding; Drug Liberation; Ethanol; Fatty Acids; Hydrophobic and Hydrophilic Interactions; Lipids; Solubility; Stearic Acids; Wettability | 2015 |
Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori.
Topics: Alginates; Anti-Infective Agents; Diglycerides; Drug Delivery Systems; Drug Liberation; Fatty Acids; Glucuronic Acid; Glycerides; Helicobacter Infections; Helicobacter pylori; Hexuronic Acids; Metronidazole; Polysaccharides, Bacterial | 2015 |
Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol.
Topics: Antiemetics; Delayed-Action Preparations; Diglycerides; Dronabinol; Drug Compounding; Drug Liberation; Drug Stability; Excipients; Fatty Acids | 2016 |
Topical Amphotericin B solid lipid nanoparticles: Design and development.
Topics: Administration, Cutaneous; Amphotericin B; Animals; Biological Transport; Diglycerides; Drug Carriers; Drug Compounding; Drug Stability; Fatty Acids; Female; Nanoparticles; Particle Size; Permeability; Poloxamer; Polysorbates; Rabbits; Rats; Rats, Wistar; Skin; Surface-Active Agents | 2016 |
A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets.
Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Diglycerides; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Storage; Excipients; Fatty Acids; Freeze Drying; Hardness; Humans; Lipids; Medication Adherence; Quetiapine Fumarate; Taste; Viscosity; Waxes | 2016 |
The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN).
Topics: Biomechanical Phenomena; Diglycerides; Fatty Acids; Hot Temperature; Lipids; Microscopy; Microspheres; Nanoparticles; Nanospheres; Particle Size; Polysorbates; Pressure; Pulmonary Surfactants; Surface-Active Agents; Triglycerides; Viscosity | 2017 |
Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
Topics: Administration, Oral; Antiemetics; Delayed-Action Preparations; Diglycerides; Drug Compounding; Drug Liberation; Drug Stability; Drug Storage; Fatty Acids; Glycerides; Humans; Hydrogen-Ion Concentration; Lipids; Meclizine; Microscopy, Electron, Scanning; Pharmaceutical Vehicles; Solubility; Spectroscopy, Fourier Transform Infrared; Water; Waxes | 2017 |
Key production parameters for the development of solid lipid nanoparticles by high shear homogenization.
Topics: Diglycerides; Drug Carriers; Drug Compounding; Fatty Acids; Lipids; Nanoparticles; Palmitates; Particle Size; Poloxamer; Stearic Acids; Surface-Active Agents | 2019 |